Share chart Zoetis
Extended chart
Simple chart
About Zoetis
Zoetis Inc. — крупнейший в мире производитель лекарств и прививок для домашних животных и скота. Компания была дочерней компанией Pfizer, крупнейшего в мире производителя лекарств, но с выделением Pfizer своей 83% -ной доли в компании, теперь она является полностью независимой компанией.Main settings
IPO date
2013-02-01
ISIN
US98978V1035
Industry
Pharmaceuticals
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Див.доход ао
1.1
Дивиденд ао
1
Сайт
Grade
Underestimation
| Title | Value | Grade |
| P/S | 7.97 | 1 |
| P/BV | 15.47 | 1 |
| P/E | 29.68 | 6 |
Efficiency
| Title | Value | Grade |
| ROA | 17.43 | 5 |
| ROE | 50.91 | 10 |
| ROIC | 19.69 | 6 |
Dividends
| Title | Value | Grade |
| Dividend yield | 1.05 | 2.63 |
| DSI | 0.9286 | 9.29 |
| Average dividend growth | 17.3 | 10 |
Debt
| Title | Value | Grade |
| Debt/EBITDA | 1.74 | 7 |
| Debt/Ratio | 0.4737 | 10 |
| Debt/Equity | 1.41 | 8 |
Growth impulse
| Title | Value | Grade |
| Yield Revenue, % | 38.56 | 5 |
| Yield Ebitda, % | 41.83 | 6 |
| Yield EPS, % | 59.81 | 7 |
Dividends
Prices
| Price | Min. | Max. | Change | Changes in the industry | Changes in the index | |
| Yesterday | 168.82 $ | 0 $ | 0 $ | 0 % | 0 % | 0 % |
| Week | 170.16 $ | 164.61 $ | 168.82 $ | -0.79 % | 0 % | 0 % |
| Month | 161.97 $ | 161.44 $ | 170.3 $ | 4.23 % | 0 % | 0 % |
| Three month | 153.55 $ | 144.41 $ | 170.3 $ | 9.94 % | 0 % | 0 % |
| Half a year | 172.24 $ | 144.41 $ | 175.67 $ | -1.99 % | 0 % | 0 % |
| Year | 181.56 $ | 144.41 $ | 196.48 $ | -7.02 % | 0 % | 0 % |
| 3 years | 156.98 $ | 130.41 $ | 200.09 $ | 7.54 % | 0 % | 0 % |
| 5 years | 166.82 $ | 130.41 $ | 247.67 $ | 1.2 % | 0 % | 0 % |
| 10 years | 50.51 $ | 39.33 $ | 247.67 $ | 234.23 % | 0 % | 0 % |
| Year to date | 157.52 $ | 144.41 $ | 175.67 $ | 7.17 % | 0 % | 0 % |
Insider trading
Main owners
Contained in ETF
| ETF | Share, % | Profitability for 1 year, % | Commission, % |
| North Shore Dual Share Class ETF | 4.48 | 0 | 0.85 |
| Alpha Intelligent - Large Cap Growth ETF | 2.48 | 0 | 0.85 |
| iShares Evolved U.S. Innovative Healthcare ETF | 2.32 | 0.000586 | 0.18 |
| ROC ETF | 2.17 | 0 | 0.49 |
| IQ Engender Equality ETF | 1.36818 | 7.62 | 0.45 |
| Columbia U.S. ESG Equity Income ETF | 0.31484 | -3.6 | 0.35 |
| iShares Morningstar Large-Cap Value ETF | 0.1905 | 53.47 | 0.25 |
| iShares Morningstar Large-Cap ETF | 0.17506 | 184.21 | 0.03 |
| iShares Morningstar Large-Cap Growth ETF | 0.16 | 264.7 | 0.04 |
| JPMorgan U.S. Aggregate Bond ETF | 0.01 | 5.07 | 0.07 |
| 1.37 | 51.15 | 0.36 |
|---|
Similar companies
P/E & P/BV
Company management
| Head | Job title | Payment | Year of birth |
| Ms. Kristin C. Peck | CEO & Director | 2.8M | 1971 (54 years) |
| Ms. Wafaa Mamilli | EVP, Chief Digital & Tech. Officer, Group President for China, Brazil and Preci. Animal Health | 1.08M | 1967 (58 years) |
| Mr. Wetteny N. Joseph | Executive VP & CFO | 1.26M | 1972 (53 years) |
| Ms. Roxanne Lagano | Executive VP, General Counsel & Corporate Secretary | N/A | 1965 (60 years) |
| Mr. Steven Frank | Vice President of Investor Relations | N/A | |
| Mr. William Price | VP & Chief Communications Officer | N/A | |
| Dr. Robert J. Polzer Ph.D. | Executive VP and President of Research & Development | N/A | 1969 (56 years) |
| Ms. Jeannette Ferran Astorga | Executive VP of Corporate Affairs & Communications and Chief Sustainability Officer | N/A | 1975 (50 years) |
| Mr. Nick Ashton | Executive VP and President of Global Manufacturing & Supply | N/A | 1973 (52 years) |
| Mr. Jamie Brannan | Executive VP and Group President International Operations of Aquaculture & Global Diagnostics | 1973 (52 years) |
About company
Address: United States, Parsippany, 10 Sylvan Way - Open in google maps, Open in yandex maps
Website: http://www.zoetis.com
Website: http://www.zoetis.com
